Field operations in FDA’s human drugs program would bear the brunt of the reductions included in the agency’s fiscal year 2016 budget request.
The proposed cuts were described as part of an effort to focus on the most important compliance and other activities, even as FDA continues its work to improve oversight of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?